“…Elevation of [Ca 2ϩ ] i in response to AhR agonists has been reported in various cellular models, including lymphocytes (Burchiel et al, 1991;Pallardy et al, 1992;Archuleta et al, 1993), macrophages (NЈDiaye et al, 2006;Pappas et al, 2003), intestinal (Le Ferrec et al, 2002), and mammary cells (Tannheimer et al, 1997) and can therefore be considered a hallmark of AhR agonist exposure. It is noteworthy that this change of [Ca 2ϩ ] i has been recently demonstrated to be required for regulation of the AhR target genes CYP1A1 and CCL1, in human Caco-2 intestinal cells (Le Ferrec et al, 2002) and human macrophages (NЈDiaye et al, 2006), respectively.…”